SOURCE-LINKED INTELLIGENCE
Discovery of new Frontal Temporal Dementia multimodal spectral markers in biofluids.
Discovery of new Frontal Temporal Dementia multimodal spectral markers in biofluids. The central aim of the project is to apply multimodal spectroscopy combined with machine learning to identify a fingerprint for Frontal Temporal Dementia (FTD) and Alzheimer’s disease (AD) in saliva and plasma. FTD is the second most common dementia and usually affects individuals younger than 60 years old. FTD is difficult to diagnose, since there is no single exam that determines the disease, but instead many costly or painful exams that together link the disease. Some of the symptoms of the disease may be confounding with others such as AD. While the usual search for biomarkers focuses on individual patterns, the present proposal is to use a holistic approach. Vibrational spectroscopy provides a snapshot of the entire chemical finger print in a label-free way. In this project, samples from FTD, AD, and healthy subjects of >45 years old, will be analysed using Raman, mid and near infrared spectroscopy @Monash University in Australia, and complemented with Mass Spec
Read original source ↗ Open in workspace
- recordType
- award
- status
- TERMINATED
- region
- EU
- value
- 287152.32
- unit
- EUR
Evidence & attribution
European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.
License: CORDIS reuse policy
First collected: 2026-09-20T01:21:06.728Z. This is not the publication date.